Shilpa Medicare Ltd

Announcement Under Regulation 30 Of The SEBI(LODR) Regulations.

10:25 AM, 17th Nov 2025

Shilpa announces the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD)